Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells

被引:124
作者
Vitale, C
Romagnani, C
Falco, M
Ponte, M
Vitale, M
Moretta, A
Bacigalupo, A
Moretta, L
Mingari, MC
机构
[1] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[3] Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy
[4] Osped San Martino Genova, Ctr Trapianti Midollo Osseo, Div Ematol, I-16132 Genoa, Italy
关键词
D O I
10.1073/pnas.96.26.15091
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
P75/AIRM1 is a recently identified surface molecule that belongs to the sialoadhesin family and displays homology with the myeloid cell antigen CD33, In lymphoid cells, p75/AIRM1 is confined to natural killer cells and mediates inhibition of their cytolytic activity. In this study, we show that p75/AIRM1 is also expressed by cells of the myelomonocytic cell lineage, in which it appears at a later stage as compared with CD33, In vitro proliferation and differentiation of cord blood-derived CD34(+) cells (induced by stem cell factor and granulocyte-macrophage colony-stimulating factor) were consistently inhibited by the addition of anti-p75/AIRM1 mAb, Engagement of CD33 led to inhibition in some experiments. A sharp decrease of cell proliferation/survival was detected in all three p75/AIRM1+ chronic myeloid leukemias analyzed when cultured in the presence of either anti-p75/AIRM1 or anti-CD33 mAbs, Thus, the present study suggests that p75/AIRM1 and CD33 may play a regulatory role in normal myelopoiesis and may be viewed as suitable target molecules to counteract the proliferation/survival of chronic myeloid leukemias.
引用
收藏
页码:15091 / 15096
页数:6
相关论文
共 19 条
  • [1] PRECURSORS OF COLONY-FORMING CELLS IN HUMANS CAN BE DISTINGUISHED FROM COLONY-FORMING CELLS BY EXPRESSION OF THE CD33 AND CD34 ANTIGENS AND LIGHT SCATTER PROPERTIES
    ANDREWS, RG
    SINGER, JW
    BERNSTEIN, ID
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) : 1721 - 1731
  • [2] CANTONI C, 2000, IN PRESS EUR J IMMUN
  • [3] CARON PC, 1995, CLIN CANCER RES, V1, P63
  • [4] CARON PC, 1994, CANCER, V73, P1049, DOI 10.1002/1097-0142(19940201)73:3+<1049::AID-CNCR2820731344>3.0.CO
  • [5] 2-1
  • [6] Caron PC, 1998, CLIN CANCER RES, V4, P1421
  • [7] DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423
  • [8] Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells
    Falco, M
    Biassoni, R
    Bottino, C
    Vitale, M
    Sivori, S
    Augugliaro, R
    Moretta, L
    Moretta, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) : 793 - 801
  • [9] CHARACTERIZATION OF CD33 AS A NEW MEMBER OF THE SIALOADHESIN FAMILY OF CELLULAR INTERACTION MOLECULES
    FREEMAN, SD
    KELM, S
    BARBER, EK
    CROCKER, PR
    [J]. BLOOD, 1995, 85 (08) : 2005 - 2012
  • [10] CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma 1 upon B cell activation
    Law, CL
    Sidorenko, SP
    Chandran, KA
    Zhao, ZH
    Shen, SH
    Fischer, EH
    Clark, EA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 547 - 560